Core Scientific Inc vs KKR & Co Inc — how do they compare? Core Scientific Inc trades at $15.41 (market cap $4.94B), while KKR & Co Inc trades at $90.95 (market cap $80.39B). The key difference: KKR & Co Inc is far larger — about 16.3× Core Scientific Inc's market cap, and KKR & Co Inc pays a 0.87% dividend while Core Scientific Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Core Scientific Inc for 20 Days and KKR & Co Inc for 67 Days on average.
| CORZ | KKR | |
|---|---|---|
Market Cap | $4.94B | $80.39B |
Volume | 15,630,800 | 6,517,705 |
Sector | Technology | Financials |
52-Week High | $29.16 | $142.75 |
52-Week Low | $13.57 | $83.88 |
Typical Hold Time | 20 Days | 67 Days |
Enterprise Value | $7.46B | $2.95B |
Dividend Yield | — | 0.87% |
Signals from Pluang's Aura AI — not financial advice
Core Scientific (CORZ) trades at $15.36, down 3.64% with bearish technical signals despite strong analyst support. The company shows significant financial challenges with a -324.9% net income margin and consecutive quarterly earnings misses, though revenue growth from $319M to $440M is projected. Recent executive appointments and insider buying signal internal confidence amid the company's pivot toward AI data center infrastructure.
The stock presents a high-risk opportunity with Wall Street maintaining bullish price targets averaging $32.75, representing 113% upside potential. However, substantial losses, negative cash flow, and competitive pressures in the AI infrastructure space create significant execution risk. Investors must weigh analyst optimism against fundamental weaknesses and market volatility.
KKR trades at $89.56, down 0.12% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. Recent earnings show a mixed track record, with Q2 2026 beating estimates but Q4 2025 missing. The company maintains strong analyst support with a consensus price target of $123.30 and 24 buy ratings. Recent news highlights active deal-making, including a joint venture with Thomson Reuters and investments in AI infrastructure, signaling ongoing strategic expansion.
The outlook for KKR is positive based on robust analyst sentiment and strategic investments, but risks include volatile cash flows and high debt levels. Investors may find opportunity in the significant upside to the price target, though macroeconomic sensitivity and execution risks warrant caution.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →KKR is one of the world's largest alternative asset managers, with $490.7 billion in total assets under management, including $384.5 billion in fee-earning AUM, at the end of June 2022. The company has two core segments: asset management (which includes private markets--private equity, credit, infrastructure, energy and real estate--and public markets--primarily credit and hedge/investment fund platforms) and insurance (following the February 2021 purchase of a 61.5% economic stake in Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance). On the asset management side, private markets account for 50% of fee-earning AUM and 70% of base management fees, while public markets account for 50% and 30%, respectively.
Read more on KKR →